Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2019-08-16

Clinical Trial Update: Optimum Thiamine Intervention (OpTIn) Trial [Phase 4]

View source ↗

Summary

Phase 4 trial update for Optimum Thiamine Intervention (OpTIn) investigating thiamine intervention in Wernicke-Korsakoff Syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Menzies School of Health Research | Conditions: Wernicke-Korsakoff Syndrome | Phase 4 | Status: COMPLETED